Pulmonary function and circulating adhesion molecules in patients with diabetes mellitus
Autore
Boulbou, M. S.; Gourgoulianis, K. I.; Petinaki, E. A.; Klisiaris, V. K.; Maniatis, A. N.; Molyvdas, P. A.Data
2003Soggetto
Abstract
Background: Lung function in diabetes has been reported in several studies with contradictory results. Diabetes mellitus increases expression of adhesion molecules through hyperglycemia. These molecules play an important role in the pathophysiological dysfunction of the vasculature. Objective: To explore the possible relationship between lung function and circulating levels of adhesion molecules in diabetes. Methods: Sixteen type 1 diabetic patients, 33 type 2 diabetic patients and 22 healthy subjects matched for age and sex were studied. Spirometry measurements were performed and pulmonary diffusion capacity for carbon monoxide (DLco) was measured in sitting and supine positions by the single-breath method corrected by alveolar volume (VA). Glycosylated hemoglobin, retinopathy and nephropathy were included as parameters of metabolic control and diabetic complications. Circulating levels of soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) were determined in all subjects. Results: Diabetic subjects showed lower variation in DLco and DLco/VA by changing posture from sitting to supine position (P=0.043 and P<0.001, respectively), and showed reduced total lung capacity (P<0.001) and forced expiratory volume in 1 s/forced vital capacity (P=0.009) compared with healthy control subjects. Serum concentrations of E-selectin were elevated in diabetic patients (P<0.001). There was no difference in serum VCAM-1 concentrations between diabetic and control subjects. On stepwise regression analysis, E-selectin concentrations were the most important contributing factor to the variation in DLco/VA. Conclusions: Diabetic patients show lower pulmonary volumes and variation in DLco by changing posture from sitting to supine position, and they also show increased levels of E-selectin. A possible explanation is impaired pulmonary microvasculature, because adhesion molecules seem to be sensitive markers of endothelial activation and damage seen in diabetes.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Cadherin and Wnt signaling pathways as key regulators in diabetic nephropathy
Tziastoudi M., Tsezou A., Stefanidis I. (2021)Aim A recent meta-analysis of genome-wide linkage studies (GWLS) has identified multiple genetic regions suggestive of linkage with DN harboring hundreds of genes. Moving this number of genetic loci forward into biological ... -
Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease
Boulbou, M. S.; Koukoulis, G. N.; Vasiou, K. G.; Petinaki, E. A.; Gourgoulianis, K. I.; Fezoulidis, I. B. (2004)Aim. Abnormal endothelial function is well known in patients with type 2 diabetes mellitus; and thought to induce macroangiopathy. Increased levels of adhesion molecules have been found in type 2 diabetic patients and it ... -
Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension
Boulbou, M. S.; Koukoulis, G. N.; Makri, E. D.; Petinaki, E. A.; Gourgoulianis, K. I.; Germenis, A. E. (2005)Background: Risk factors for atherosclerosis such as hypertension, type 2 diabetes, obesity and dyslipidemia affect endothelial function and stimulate adhesion molecules expression. The aim of the study was to examine ...